Filter Results:
(993)
Show Results For
- All HBS Web
(993)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
Show Results For
- All HBS Web
(993)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
- 15 Jan 2018
- Research & Ideas
A Better Business Model for Fighting Cancer
benefits of sharing data, which can then be used to more quickly identify the most pressing targets and design trials to address them. Innovations to the typical clinical trial model are also being used. In an adaptive platform trial, for example, different View Details
- Web
Esther Koh | MBA
Tech Fellow, I can gain the strong foundation necessary to launch such ventures in a dynamic biotech environment alongside fellow builders on campus. Tech areas of interest: Biotech, medical devices, biomaterials, drug design and... View Details
- 25 Apr 2014
- News
Disrupting criminal enterprises that prey on children
Kayla Brochu (MBA/JD 1999) deployed business and legal strategies to combat some of the world's worst crimes as the United Nations Office on Drugs and Crime Expert on Technology-Facilitated Child Abuse, Exploitation, and Trafficking.... View Details
- Web
Consumer Information | MBA
Disabilities Career and Professional Development Drug and Alcohol Prevention Retention and Graduation Rates Campus Security Fire Safety Student Records Policy (FERPA) University Wide Consumer Information View Details
- 11 May 2021
- News
Pitching to Win
the five grand-prize winners. Goble is co-founder of Karivez Bio, a platform for transforming chronic disease treatment through improved drug delivery. Okrah is founder and CEO of Chaku Foods, a fast-moving consumer goods company based in... View Details
- 10 Sep 2008
- Research & Ideas
Long-Tail Economics? Give Me Blockbusters!
by focusing on bigger films that require a bigger commitment." Jeff Robinov believes in blockbusters and his strategy is to create more of them. The pharmaceutical and entertainment industries are similar. R&D costs in both are high. Results are unpredictable.... View Details
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
time, Imprimis was in the process of seeking FDA approval for a branded drug called Impracor. This process, already difficult, was further complicated by recent manufacturing issues. Meanwhile, the opportunity arose for Imprimis to... View Details
Keywords: Sean Silverthorne
- Web
Neil Band | MBA
track in tech entrepreneurship. Tech areas of interest: I’m fascinated by the application of machine learning, distributed systems, and cryptography to economics and biology. I currently research memory optimization in deep neural network training, and reinforcement... View Details
- 16 Sep 2016
- News
Gaining Ground on ALS
Bucket Challenge to support the Phase 3 trial of a promising investigational drug that is designed to slow the loss of lung function and muscle strength in patients with ALS. “Clinical trials cost tens to hundreds of millions of dollars,”... View Details
- 08 Mar 2016
- First Look
March 8, 2016
cultural model and undermine their own positions with inappropriate use of symbolic market-creation actions. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=50701 Harvard Business School Case 916-026 Express Scripts: Promoting Prescription View Details
Keywords: Sean Silverthorne
- 04 Sep 2019
- News
Accelerating Scientific Discovery
reduce human disease and suffering influences his work as a health care economist and researcher. “I imagine a world where we have treatments, ideally cures, for diseases where right now we have nothing,” he says. “So the big questions that motivate me are, what are... View Details
Keywords: Jennifer Gillespie
Justin Dart
Dart transformed United Drug into a profitable firm again. He did this by going with the Rexall banner, which the founder Louis Liggett had made into a household name, and discarding most of the other names in use by the company.... View Details
Keywords: Retail
- 01 Sep 2011
- News
Alumni Team Up to Fight Cancer
networking among its alumni community. Bowes, founding partner of US Venture Partners, and Giusti, founder of the Multiple Myeloma Research Foundation (MMRF), discussed the need for innovative, results-oriented biomedical research and View Details
- Web
1.0 MBA Standards of Conduct | MBA
1.3.4 Classroom Recording, Photography & Social Media 1.3.5 Classroom Non-Attribution 1.3.6 Academic Retaliation 1.4 Community Standards of Conduct 1.4.1 Recruiting Standards of Conduct 1.4.2 Drug and Alcohol Policy 1.4.3 Anti-Hazing... View Details
- Student-Profile
Olivia Zhao
pros and cons of a public system facing increased privatization. Research Olivia’s research hones in on the pharmaceutical industry and looking at the lifecycle of a drug. “It starts, of course, with research and development at huge drug... View Details
- 01 Jun 2018
- News
Floor It
case study with the Multiple Myeloma Research Foundation, GNS Healthcare, the Moffitt Cancer Center’s ORIEN program, and biotech firm Foundation Medicine. Rethinking Drug Trials In an adaptive platform trial, different View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 01 Sep 2008
- News
In Africa, Porter Sees Lessons for Health Care
delivery systems of both developing and advanced countries: fragmentation, inefficiency, and organization around discrete interventions (such as delivering drugs or screening) rather than integrated care. Porter and his colleagues aim to... View Details
- Web
Suppliers - Institute For Strategy And Competitiveness
carefully examine the outcomes relative to cost for every new drug and device introduced. Key Action Steps for Suppliers Base strategies on creating unique value for patients Focus on cycles of care rather than narrow product usage Sell... View Details
- Fast Answer
Patent search: Cortellis
How can I begin a patent search in Cortellis and can I search by therapeutic areas, e.g.? Cortellis for Competitive Intelligence combines a collection of pharmaceutical industry data and life science related content into a single platform including news,... View Details
- 01 Jun 2018
- News
The Long Run
trajectory of overdose deaths from prescription drugs and heroin. According to the Centers for Disease Control and Prevention, the US death rate from opioid overdose has increased over 400 percent since 1999; the picture is even grimmer... View Details